Kudlow Paul, Burns Karen E A, Adhikari Neill K J, Bell Benjamin, Klein David J, Xie Bin, Friedrich Jan O, Wald Ron
Crit Care. 2014 Sep 17;18(5):513. doi: 10.1186/s13054-014-0513-1.
Patients with severe acute kidney injury (AKI) who are hospitalized at centers that do not provide renal replacement therapy (RRT) are frequently subjected to inter-hospital transfer for the provision of RRT. It is unclear whether such transfers are associated with worse patient outcomes as compared with the receipt of initial care in a center that provides RRT. This study examined the relationship between inter-hospital transfer and 30-day mortality among critically ill patients with AKI who received RRT.
We conducted a retrospective cohort study of all critically ill patients who commenced RRT for AKI at two academic hospitals in Toronto, Canada. The exposure of interest was inter-hospital transfer for the administration of RRT. We evaluated the relationship between transfer status and 30-day mortality (primary outcome) and RRT dependence at 30 days following RRT initiation (secondary outcome), by using multivariate logistic regression with adjustment for patient demographics, clinical factors, biochemical indices, and severity of illness.
Of 370 patients who underwent RRT for AKI, 82 (22.2%) were transferred for this purpose from another hospital. Compared with non-transferred patients who started RRT, transferred patients were younger (61 ± 15 versus 65 ± 15 years, P = 0.03) and had a higher serum creatinine concentration at RRT initiation (474 ± 295 versus 365 ± 169 μmol/L, P = 0.002). Inter-hospital transfer was not associated with mortality (adjusted odds ratio 0.61, 95% confidence interval 0.33 to 1.12) or RRT-dependence (adjusted odds ratio 1.64, 95% confidence interval 0.70 to 3.81) at 30 days.
Within the limitations of this observational study and the potential for residual confounding, inter-hospital transfer of critically ill patients with AKI was not associated with a higher risk of death or dialysis dependence 30 days after the initiation of acute RRT.
在未提供肾脏替代治疗(RRT)的中心住院的重症急性肾损伤(AKI)患者经常需要转院以接受RRT。与在提供RRT的中心接受初始治疗相比,这种转院是否会导致更差的患者预后尚不清楚。本研究探讨了接受RRT的重症AKI患者院间转院与30天死亡率之间的关系。
我们对加拿大多伦多两家学术医院中所有因AKI开始接受RRT的重症患者进行了一项回顾性队列研究。感兴趣的暴露因素是因RRT管理而进行的院间转院。我们通过多因素逻辑回归分析,对患者人口统计学、临床因素、生化指标和疾病严重程度进行调整,评估了转院状态与30天死亡率(主要结局)以及RRT开始后30天的RRT依赖情况(次要结局)之间的关系。
在370例接受AKI-RRT的患者中,82例(22.2%)是从另一家医院转来接受该治疗的。与开始RRT的非转院患者相比,转院患者更年轻(61±15岁对65±15岁,P = 0.03),且RRT开始时血清肌酐浓度更高(474±295对365±169μmol/L,P = 0.002)。院间转院与30天死亡率(调整后的优势比0.61,95%置信区间0.33至1.12)或RRT依赖情况(调整后的优势比1.64,95%置信区间0.70至3.81)无关。
在本观察性研究的局限性以及潜在残留混杂因素的影响下,重症AKI患者在急性RRT开始后30天进行院间转院与更高的死亡风险或透析依赖风险无关。